NCT01697969View on ClinicalTrials.gov

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Olopatadine hydrochloride ophthalmic solution, 0.2%

Trial Locations (1)

52242-1091

University of Iowa, Iowa City

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01697969 - Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients | Biotech Hunter | Biotech Hunter